The Journal of Immunology · 2009 · 33 citations · 25 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer Cell-cell CommunicationStromal Cell InteractionsTumor Immune MicroenvironmentTumor Microenvironment InteractionsTumor-associated AntigensTumor-stroma InteractionsCytotoxic T Lymphocyte EpitopesCytotoxic T Lymphocyte FunctionGap Junction Intercellular CommunicationGap Junctions In CancerTumor Microenvironment CommunicationTumor Microenvironment EffectsTumor Rejection AntigensVascular Endothelial Junctions
Cellular interactions in the tumor stroma play a major role in cancer progression but can also induce tumor rejection. To explore the role of endothelial cells in these interactions, we used an in vitro three-dimensional collagen matrix model containing a cytotoxic T lymphocyte CTL clone (M4.48), autologous tumor cells (M4T), and an endothelial cell (M4E) line that are all derived from the same tumor. We demonstrate in this study that specific killing of the endothelial cells by the CTL clone required the autologous tumor cells and involved Ag cross-presentation. The formation of gap junctions between endothelial and tumor cells is required for antigenic peptide transfer to endothelial cells that are then recognized and eliminated by CTL. Our results indicate that gap junctions facilitate an effective CTL-mediated destruction of endothelial cells from the tumor microenvironment that may contribute to the control of tumor progression.
25
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Joseph Wolfers, Anne Lozier, Graça Raposo et al. · Nature Medicine · 2001 · 1.6K citations
Life Sciences, Immunology, Oncology +16
Cross-presentation by intercellular peptide transfer through gap junctions
Joost Neijssen, Carla Herberts, Jan W. Drijfhout et al. · Nature · 2005 · 436 citations